12 February 2024. Neomatrix was granted 258.751,70 for a Research Project on Breast Cancer. VAP (Vaccine Ad Personam) aims to establish a new therapy based on Neomatrix technology in the context of breast cancer. In order to understand the feasibility of this innovative therapeutic approach, Neomatrix has entered into collaboration with Professor Silvia Piconese to perform molecular and immunological characterizations in the complex context of breast cancer ... (read more)
April 8, 2021 - Neomatrix awarded at BioinItaly Investment Forum. Neomatrix awarded at BioinItaly Investment Forum Neomatrix was among the four start-ups awarded at the “BioinItaly Investement Forum & Intesa San Paolo start up initiative” in the Life Sciences sector, with a novel personalized approach to ... (read more)